Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Adherium Ltd. ( (AU:ADR) ).
Adherium Limited has issued 25,510,000 fully paid ordinary shares and lodged a cleansing notice under section 708A of the Corporations Act 2001, confirming that the shares were issued without a disclosure document and that the company remains compliant with its financial reporting and continuous disclosure obligations. The company also stated there is no excluded information that must be disclosed, indicating the new share issue is being conducted within the existing regulatory framework and should be readily tradeable for investors under Australian securities law.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Adherium Limited is an Australian digital health company and a global leader in connected respiratory medical devices. Through its Hailie® platform, the company offers integrated solutions that enable clinicians, healthcare providers and patients to remotely monitor medication usage and adherence in respiratory disease, supported by mobile and desktop applications, SDK and API integration tools, and a proprietary range of sensors connected to respiratory medications.
Technical Sentiment Signal: Sell
Current Market Cap: A$18.39M
Learn more about ADR stock on TipRanks’ Stock Analysis page.